The global Drug Eluting Stents (DES) market valued at $5.75 billion in 2007 is expected to grow by 7.2% during 2007-2012 to reach $8.15 billion by 2012.
Cardiovascular and Orthopedic Devices Markets Have the Highest Number of Pipeline Products in 2010
Page 1 of 1